Japanese Consumer Finance Stock News

TSE:4506
TSE:4506Pharmaceuticals

Sumitomo Pharma (TSE:4506) Q4 EPS Loss Tests Bullish Margin Narratives

Sumitomo Pharma (TSE:4506) has wrapped up FY 2026 with fourth quarter revenue of ¥105.5 billion and a basic EPS loss of ¥2.04, capping a year in which trailing twelve month EPS came in at ¥269.0 on revenue of ¥453.3 billion. Over recent periods, the company has seen quarterly revenue move from ¥105.6 billion in Q4 FY 2025 to ¥108.0 billion in Q1 FY 2026, ¥119.1 billion in Q2, and ¥120.6 billion in Q3 before landing at ¥105.5 billion in Q4. EPS shifted from ¥6.08 to ¥28.21, ¥220.63, ¥22.19 and...